Equities

Sawai Group Holdings Co Ltd

Sawai Group Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,972.00
  • Today's Change-2.50 / -0.13%
  • Shares traded714.00k
  • 1 Year change+18.04%
  • Beta0.6764
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Sawai Group Holdings Co Ltd grew revenues 8.04% from 163.70bn to 176.86bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 8.12% net income growth from 12.67bn to 13.70bn.
Gross margin30.73%
Net profit margin6.80%
Operating margin10.99%
Return on assets3.17%
Return on equity7.97%
Return on investment4.24%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Sawai Group Holdings Co Ltd fell by 6.71bn. However, the company earned 12.09bn from its operations for a Cash Flow Margin of 6.83%. In addition the company generated 2.36bn cash from financing while 23.11bn was spent on investing.
Cash flow per share217.38
Price/Cash flow per share9.14
Book value per share1,623.19
Tangible book value per share1,442.32
More ▼

Balance sheet in JPYView more

Sawai Group Holdings Co Ltd has a Debt to Total Capital ratio of 31.69%, a higher figure than the previous year's 27.31%.
Current ratio2.89
Quick ratio1.39
Total debt/total equity0.464
Total debt/total capital0.3169
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 46.93%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.57%
Div growth rate (5 year)0.00%
Payout ratio (TTM)36.67%
EPS growth(5 years)-2.37
EPS (TTM) vs
TTM 1 year ago
18.13
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.